Early Total Enteral Feeding Versus Convention Enteral Feeding in Preterm Infants 27-32 Weeks of Gestation (ETEFVsCEF)

August 12, 2024 updated by: Sushma Nangia, M.D., Lady Hardinge Medical College

Early Total Enteral Feeding Versus Convention Enteral Feeding in Preterm Neonates Between 27 to 32 Weeks of Gestation: A Randomized Control Trial

The objective of the study is to compare the time of attainment of full enteral feeds in preterm neonates between 27-32 weeks of gestation started on early total enteral feeding (ETEF) with those started on conventional enteral feeding (CEF).

Study Overview

Detailed Description

Enrolled participants will be randomly assigned to one of two study groups: 1) early total enteral feeding (ETEF) or 2) conventional enteral feeding (CEF). Regardless of study group assignment, mother's own breast milk (MOM) is the feed of choice and donor human milk is being offered if the MOM is not enough to complete the intervention as assigned

Intervention group: Feeds will be initiated with a target volume of 80 ml/kg/day starting within the first two hours after birth. Volumes will increased by 20 ml/kg/day till day 4 (total 140 ml/kg/d) and then 150ml/kg/day on day 5.

Control group: This group will receive enteral feeding volumes at a rate of 20 ml/kg/day starting within the first two hours after birth and rest of the daily requirement as Total parenteral nutrition. Volumes will be increased by 20 ml/kg/day till day 3 and thereafter by 30 ml/kg/d till 150ml/kg/day on day 6.

Study Type

Interventional

Enrollment (Actual)

183

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Delhi
      • New Delhi, Delhi, India, 110001
        • Lady Hardinge Medical College

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

Preterm neonate with gestational age of 27-32 weeks

Exclusion Criteria:

  1. Antenatally diagnosed GI malformation
  2. Baby born with absence or reversal of end diastolic flow on antenatal umbilical artery Doppler.
  3. Presence of major congenital anomalies at birth
  4. Need of vasopressor support at the time of randomization
  5. Requiring Positive Pressure Ventilation > 60 sec with APGAR score < 4 at 1 minute

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Early Total Enteral Feeding
Mom's milk or donor milk at 80 ml/kg/day after randomization within the first 2 hours
This group will receive enteral feeding volumes at a rate of 80 ml/kg/day starting within the first two hours after birth. Volumes will increased by 20 ml/kg/day till day 4 (total 140 ml/kg/d) and then 150ml/kg/day on day 5.
Active Comparator: Conventional Enteral Feeding
Mom's milk or donor milk at 20 ml/kg/day and rest of the requirement as Total parenteral nutrition after randomization within the first 2 hours.
This group will receive enteral feeding volumes at a rate of 20 ml/kg/day starting within the first two hours after birth and rest of the daily requirement as Total parenteral nutrition. Volumes will be increased by 20 ml/kg/day till day 3 and thereafter by 30 ml/kg/d till 150ml/kg/day on day 6.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time of attainment of full enteral feeds (150ml/kg/day) during the first 28 days after birth
Time Frame: Birth to 28 days
Days to attain full feeds during the first 28 days after birth
Birth to 28 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of episodes of feeding intolerance
Time Frame: From Randomization till 28 days after birth
Feed intolerance will be defined as any one or more of the following a) Vomiting 3 or more in any 24 hour period, b) Any episode of blood stained or bilious vomiting, c) Abdominal girth(AG) increase >2 cm (with pre-feed aspirate >25%), abdominal wall erythema or tenderness, gross or occult blood in stools
From Randomization till 28 days after birth
Incidence of Necrotising Enterocolitis
Time Frame: From Randomization till 28 days after birth
Diagnosis of necrotizing enterocolitis any stage
From Randomization till 28 days after birth
Incidence of Sepsis
Time Frame: From randomization till 28 days after birth
Sepsis will be defined as any one of the following in a symptomatic neonate a) Culture positive sepsis b) Sepsis screen positive, c) Strong clinical suspicion such as sclerema, shock or clinical deterioration on supportive therapy which warrants initiation of antibiotics (clinician decision)
From randomization till 28 days after birth
Total duration of intravenous fluid usage
Time Frame: From randomization till 28 days after birth
Duration in completed days for which infant required parenteral fluid support
From randomization till 28 days after birth
Time of regaining birth weight
Time Frame: From randomization till 28 days after birth
Duration in completed days required to regain birth weight
From randomization till 28 days after birth
Total duration of hospital stay
Time Frame: From randomization till 2 months after birth
Duration in completed days required for treatment till discharge home or till death
From randomization till 2 months after birth
Weight gain per kg per day at 1 month of age
Time Frame: Birth to 30 days
The weight in grams at one month of age minus the birth weight divided by the average weight (average weight =birth weight +Weight at 1 month age divided by 2) further divided by 30
Birth to 30 days
Extrauterine growth retardation (EUGR)
Time Frame: Till 36 weeks Postmenstrual age
Weight of the infants at 36 weeks Postmenstrual age or at discharge (if earlier) below the 10th centile for age
Till 36 weeks Postmenstrual age

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Sushma Nangia, DM (NEO), Lady Hardinge Medical College

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 11, 2022

Primary Completion (Actual)

January 10, 2024

Study Completion (Actual)

January 10, 2024

Study Registration Dates

First Submitted

August 31, 2023

First Submitted That Met QC Criteria

October 6, 2023

First Posted (Actual)

October 10, 2023

Study Record Updates

Last Update Posted (Actual)

August 13, 2024

Last Update Submitted That Met QC Criteria

August 12, 2024

Last Verified

August 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Enteral Feeding Intolerance

Clinical Trials on Early Total Enteral Feeding

Subscribe